South Africa Sahpra Medical Device Registration Service

Scope and evidence must be confirmed before any paid tests or filings.

A South Africa SAHPRA medical device registration service should begin by identifying the precise regulatory output: an establishment licence, an update to its device list, or an individual product-registration submission where SAHPRA has opened the relevant route. These are not interchangeable approvals.

What can actually be filed with SAHPRA now?

SAHPRA currently operates establishment licensing for medical device and in-vitro diagnostic (IVD) manufacturers, distributors/importers and wholesalers. Its medical-devices page says the broader phased product-registration process is still in development. A licence product list is not evidence that SAHPRA has granted an individual device registration certificate.

Before stating that a licence is required, check SAHPRA position statement 9.106 on non-sterile, non-measuring Class A devices and the actual activities. An exemption from establishment licensing must not be generalized to every Class A device or to unrelated safety, quality or other regulatory obligations. A voluntary feasibility study is not a universal product-registration filing window.

SAHPRA’s ISO 13485 communication separately states that certification duties are not necessarily removed by a Section 22C licensing exemption. Check both the Class A position statement and the current certification phase; do not treat a licensing exemption as proof that no quality-system obligations remain.

Route matrix: identify the application before collecting files

Match the South African establishment, its actual activities and the proposed devices to the correct output. Classification under SAHPGL-MD-04 is a prerequisite for coherent device listing; it does not itself create a product-registration route.

Situation / activity	Correct filing object	Critical boundary
Local manufacturer; production, packaging or labelling	Manufacturer establishment licence: GLF-MD-06A	Scope must match activities and QMS; manufacturer licence includes stated import/distribution functions.
Importer / distributor / exporter without manufacturing	Distributor establishment licence: GLF-MD-06C	A foreign OEM certificate does not replace the local establishment licence.
Local wholesaler storing and supplying from domestic sources	Wholesaler establishment licence: GLF-MD-06B	Wholesaler licence alone does not permit import/export in its own right.
Device proposed for separate individual registration	Product dossier only for a verified call-up, invitation or applicable route	Establishment device listing and product-registration certificate are different results.

Who owns the filing and who communicates with SAHPRA?

The establishment is the licence applicant. It must designate an authorised representative who is a natural person based in South Africa and accountable for regulatory communication. For a future individual device-registration application, Regulation 8 requires a person residing and doing business in South Africa and the particulars of a South African authorised representative. A foreign manufacturer should therefore settle the local contracting and evidence-access arrangements before filing; engaging a consultant does not automatically transfer the licence holder’s legal duties.

If distribution, storage or another licensed activity is outsourced, verify that the contracted establishment holds the SAHPRA establishment licence appropriate to its work. Record the site, licence number, operating scope and written quality/traceability responsibilities; a contract alone is not the required licence.

GLF-MD-06A/B/C dossier: document and GMDN checks

Entity and role evidence: correct company details, site activities, locally based authorised representative’s CV and accountable signatory.
Current appropriate GLF-MD-06A/06B/06C form completed as downloaded Excel, plus an initialled and signed PDF copy; use the latest version.
Signed cover letter to the CEO, attention Medical Device Unit, explaining the transaction and enumerating all annexures.
Controlled device list: manufacturer/supplier, device family/model, intended purpose, risk class, GMDN code, and existing authorisations where relevant; reconcile the list with proposed licensed activities.
Quality Manual for manufacturers/distributors or Site Master File for wholesalers; ISO 13485 evidence where applicable under the current phase and SAHPRA-recognised conformity-assessment rules.
SAHPRA application-fee proof and conditional attachments. COVID-19, HIV or Mpox IVD listings may require OEM ISO 13485, reference-market authorisation, labelling/IFU, technical and validation data, and WHO evidence where relevant.

For the device list use the SAHPRA-requested GMDN code and descriptor, not an EMDN code as a substitute. Cross-check the original manufacturer, intended purpose, risk class and every model/family against the source documents before submitting.

Submission workflow: from intake to licence decision

Verify product intended use, risk classification, site activities, possible Class A licensing exception and whether an individual product call-up exists; document unanswered points.
Confirm the South African applicant and authorised representative; obtain manufacturers’ evidence permissions, QMS documents and a complete device-list export.
Select the live SAHPRA form and fee notice; populate Excel, produce the signed/initialled PDF and cross-check names, addresses, classes and annexures.
Submit via the route SAHPRA currently specifies for this application. Its device-licensing FAQ names mdadmin@sahpra.org.za (and COVID-19 test-kit copying rules); confirm before dispatch whether a newer SAHPRA portal flow applies to the selected licence type. Retain acknowledgement and attachments.
Track administrative screening and substantive questions. Assign every SAHPRA observation an owner, evidence reference and reply date; reply within the period stated in the actual letter rather than assuming historic guidance always governs.
Record the decision, any issuing-fee instruction and final licence. Check approved activities/classes/listing against the request; set follow-up controls for changes, renewal, retention and safety reporting.

SAHPRA’s current establishment-licensing FAQ specifies a response to an observation letter within two working days. Triage a deficiency immediately, verify the deadline in the actual notice and request written clarification or an extension from SAHPRA without assuming it will be granted.

Product-registration dossier: prepare without assuming a call-up

For a product that has actually been called up or specifically invited, Regulation 8 identifies a proposed label, instructions for use, relevant licence/QMS and conformity documentation, other requested evidence and the application fee. The official technical-dossier guidance distinguishes IVD submissions from non-IVD submissions; verify the current version and applicable call-up conditions instead of sending an unsolicited generic dossier.

SAHPRA’s 2026 medical-device reliance guideline describes how the authority may use prior regulatory assessments, including for product registration. A foreign approval, WHO prequalification or an ISO certificate is evidence to assess, not an automatic SAHPRA authorisation. Match brand, model, manufacturing sites, indications and versions across the claimed reference approval and South African device list.

Regulation 8(4) requires the information accompanying an individual product-registration application to be at least in English. Keep the English technical evidence available even when commercial materials are translated into other languages.

SAHPRA licence applications: prevent form, product-list and scope objections

Failure mode	Pre-submission or response control
Wrong GLF-MD-06 licence type or wrong licence holder	Compare real manufacturing/import/wholesale activities and South African entity before paying; a change of licence type can require a fresh application.
Excel and signed PDF disagree; annexures or payment missing	Run field-by-field parity and signed-document checks; keep official bank proof and current fee notice.
Device list, risk class, OEM identity or QMS scope conflict	Reconcile labels, intended uses, GMDN/classes, certificate scope and contracted sites before responding to observations.
Treating listing, a pilot invitation or foreign clearance as full registration	Keep licence/listing and any separately authorised product dossier in different registers; verify notices and retain the actual SAHPRA decision.

After issue: notifications, amendments and renewal

Regulation 6 provides a five-year validity period from issue for an establishment licence. Calculate the renewal filing threshold from the actual expiry date shown on the issued licence, not from an estimated review time.

After issue, keep the licensed activities and device listing current. SAHPRA distinguishes an amendment affecting details on the issued licence from a notification that changes application/product-list information without affecting those details. A new unapproved class, change of authorised representative or address generally belongs in the amendment route; additions within an already approved class may use notification, subject to SAHPRA’s specific rules for certain test kits.

Track retention payments, vigilance, quality-system evidence and licence expiry. SAHPRA’s current licensing FAQ requires renewal submission at least 90 days before expiry; late renewal may require a new application and an expired licence does not authorise trading. The ISO 13485 certificate phase-in differs by licence activity and filing stage: check the current SAHPRA communication rather than applying a single rule to every wholesaler or new applicant.

For a product-list notification, the published FAQ specifies an authorised-representative-signed declaration that the updated list does not change already approved device classes, the current Excel form, signed PDF and licence copy; the notification is reviewed and may be rejected. A licence amendment instead requires an explanation of each changed licence field, the form and applicable supporting/payment evidence. Additions or removals of COVID-19 or Mpox test kits are amendments, even if a general same-class notification would otherwise seem suitable.

SAHPRA says not to submit an amendment, notification or renewal while another such application remains open. Notification-type list updates may be included with a renewal, but amendment-type changes cannot. Its FAQ also says renewal submitted fewer than 90 days before expiry will not be accepted: plan a fresh licence application where required, and do not trade on an expired licence.

For planning as of October 2026, SAHPRA communication MD01-2025/2026 provides a phased ISO 13485 schedule for manufacturers and distributors/importers: renewal evidence from 1 June 2025 (certificate or recognised CAB agreement where certification is in progress); Phase 3 from 1 April 2026 for existing holders already possessing a certificate; amendments and list notifications scheduled from 1 June 2027; and new licence applications scheduled from 1 April 2028. SAHPRA’s current medical-device notice says Phase 3 is in effect and gives mdqueries@sahpra.org.za for certificate submissions. These are authority implementation instructions, not dates on which a product-registration call-up automatically opens; recheck the current version and how it applies to the licence holder.

What the SAHPRA filing service hands over to the licence holder

A defensible service output is a route memorandum, role confirmation, reconciled product register, version-controlled forms and evidence index, signed submission pack, payment trail, correspondence/deficiency log and handover calendar. It cannot promise approval or a universal product-registration date. For broader non-device regulatory routing, use the separate South Africa market-access overview.

South Africa product compliance and market-access services

SAHPRA filing: practical questions

Does listing my device on an establishment licence mean the product is registered?

No. SAHPRA requires a device list for the establishment filing, while its general product-registration call-up is being developed. Obtain evidence of a separate product decision if one is claimed.

Can a foreign manufacturer file without a South African applicant or representative?

Do not assume so. Establishment licensing is tied to the local operating entity and a South Africa-based natural-person authorised representative; Regulation 8 also sets South African applicant and representative particulars for individual registration. Confirm the roles before preparing the pack.

Can a wholesaler licence be used to import medical devices?

Not by itself. SAHPRA states that wholesaler licensing does not authorise imports or exports; a distributor or manufacturer route may be required according to the real activities.

What changes when COVID-19, HIV or Mpox IVD tests appear on the product list?

SAHPRA specifies extra OEM quality, foreign authorisation, labelling and technical evidence for relevant test kits. COVID-19/Mpox product additions or removals may be treated as amendments rather than routine notifications; check the live instruction.

Can I add a device after the licence is issued or file renewal while an amendment is open?

Same-class additions may qualify for notification; adding a class outside the approved scope usually requires amendment. SAHPRA says concurrent pending amendment/notification/renewal filings are not accepted; finish the open matter and protect the 90-day renewal window.